As of 2025-11-10, the Intrinsic Value of Ergomed PLC (ERGO.L) is 677.37 GBP. This ERGO.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1,346.00 GBP, the upside of Ergomed PLC is -49.70%.
The range of the Intrinsic Value is 538.42 - 942.73 GBP
Based on its market price of 1,346.00 GBP and our intrinsic valuation, Ergomed PLC (ERGO.L) is overvalued by 49.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 538.42 - 942.73 | 677.37 | -49.7% |
| DCF (Growth 10y) | 767.05 - 1,338.52 | 965.05 | -28.3% |
| DCF (EBITDA 5y) | 1,102.49 - 1,419.48 | 1,296.66 | -3.7% |
| DCF (EBITDA 10y) | 1,244.27 - 1,734.40 | 1,510.64 | 12.2% |
| Fair Value | 734.51 - 734.51 | 734.51 | -45.43% |
| P/E | 1,070.04 - 1,374.01 | 1,294.44 | -3.8% |
| EV/EBITDA | 717.38 - 1,088.88 | 975.88 | -27.5% |
| EPV | 390.86 - 498.51 | 444.68 | -67.0% |
| DDM - Stable | 199.67 - 490.87 | 345.27 | -74.3% |
| DDM - Multi | 435.61 - 846.49 | 576.69 | -57.2% |
| Market Cap (mil) | 687.33 |
| Beta | 1.02 |
| Outstanding shares (mil) | 0.51 |
| Enterprise Value (mil) | 664.32 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.84% |
| Cost of Debt | 6.61% |
| WACC | 10.82% |